Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesia Regimens During Concurrent Chemoradiation for Head and Neck Cancer
NCT02531906Phase 1Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Apr 2015
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in pain and stomatitis comparing Arm I (gabapentin) with Arm II (gabapentin, methadone, oxycodone) (2 arms). Primary endpoints: Change in pain levels at 24 months, Incidence of side effects or drug intolerance at 24 months and 1 more. Started Apr 2015; status: completed.
02
Drugs
gabapentinmethadoneoxycodone
03
Conditions
painstomatitis
Beyond the preview
Go deeper on NCT02531906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531906.